Nonalcoholic fatty liver disease

Results 71 to 80 of about 172,507 (213)

The effectiveness of metformin in patients with metabolic syndrome and nonalcoholic fatty liver disease

Ожирение и метаболизм, 2008
The mechanism of action of metformin is realized through activation of cAMP-dependent protein kinase, leading to a decrease hepatic glucose production as well as to decrease the synthesis of triglycerides and an increase in fat oxidation. Several studies
S A Butrova, A Yu Eliseeva, A V Il'in
doaj +1 more source

Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey‐Based Study

, 2021
Oliver Glass +6 more
openalex +1 more source

Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes

Journal of Obesity & Metabolic Syndrome, 2018
Background : Vitamin D deficiency is known to increase the incidence of metabolic syndrome. Nonalcoholic fatty liver disease is a common metabolic disease in patients with type 2 diabetes.
Dug-Hyun Choi +5 more
doaj +1 more source

Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome [PDF]